Biocon

BIOCON02 May 2024

Pharmaceuticals

₹

+12.45 (+4.17%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Biocon

Biocon

Pharmaceuticals

BIOCON02 May 2024

₹

+12.45 (+4.17%)

OverviewFundamentalsFutures Options

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
23-May-2023	D	The Board recommended a final dividend at the rate of 30% i.e. Rs. 1.50/- per equity share of face value of Rs. 5/- each for the financial year ended March 31, 2023, subject to shareholders' approval at the ensuing Annual General Meeting ('AGM'). Pursuant to Regulation 42 of SEBI Listing Regulations, the Company has fixed Friday, July 7, 2023 as the record date for determining entitlement of members to final dividend for the financial year ended March 31, 2023. The dividend will be paid on or before September 8, 2023.	07-Jul-2023
28-Apr-2022	D	Board Recommended a final dividend at the rate of 10% i.e. Re. 0.50/- per equity share of face value of Rs. 5/- each for the financial year ended March 31, 2022, subject to shareholders' approval at the ensuing Annual General Meeting (AGM') and record date for payment of final dividend is July 1, 2022. The dividend will be paid within 30 (thirty) days from the date of shareholders' approval at the ensuing 44th AGM.	30-Jun-2022
25-Apr-2019	D	Biocon Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 25, 2019, inter alia, has considered and approved the following : Recommended final dividend of Re. 1 per equity share offace value of Rs. 5/- each (Pre-bonus issue) for the financial year ended March 31, 2019, subject to shareholders' approval at the ensuing Annual General Meeting ('AGM'). The dividend will be paid within 30 days from the date of shareholder's approval at the ensuing Annual General Meeting. Dividend Updates (As Per BSE Announcement Dated on 04/07/2019)	18-Jul-2019
26-Apr-2018	D	Biocon Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 26, 2018, inter alia, has proposed a final dividend of Re 1 per equity share. The proposed dividend is subject to the approval of the shareholders in the Annual General Meeting.	19-Jul-2018
27-Apr-2017	D	Audited Financial Results for the quarter and year ended March 31, 2017.	20-Jul-2017
11-Mar-2016	D	Biocon Ltd has informed BSE that the Board of Directors of the Company has approved the payment of interim dividend at a rate of 100% i.e. (Rs. 5 per share) for the financial year 2015-16 vide circular resolution dated March 11, 2016.	17-Mar-2016
27-Mar-2015	D	Biocon Ltd has informed BSE that, the Board of Director vide its Circular resolution dated March 26, 2015, has approved the payment of Interim Dividend at a rate of 100% i.e. (Rs. 5/- per share) for the Financial Year 2014-15.	09-Apr-2015
25-Apr-2014	D	Biocon Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 24, 2014, inter alia, has recommended a final dividend of Rs. 5/- per share (i.e. 100%) for the financial year 2013-14. The declaration of dividend is subject to shareholders' approval at the ensuing Annual General Meeting of the Company to be held during July 2014.	10-Jul-2014
26-Apr-2013	D	Biocon Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 25, 2013 inter alia, has recommended a final dividend of Rs. 5/- per share (i.e. 100%) and a special dividend of Rs. 2.50/- per share (i.e.50%) for the financial year 2012-13. The declaration of dividend is subject to shareholders's approval at the ensuing Annual General Meeting of the Company. Subsequent to Shareholders' approval the dividend will be paid within a period of 30 days from the date of such approval.	11-Jul-2013
26-Apr-2013	D	Biocon Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 25, 2013 inter alia, has recommended a final dividend of Rs. 5/- per share (i.e. 100%) and a special dividend of Rs. 2.50/- per share (i.e.50%) for the financial year 2012-13. The declaration of dividend is subject to shareholders's approval at the ensuing Annual General Meeting of the Company. Subsequent to Shareholders' approval the dividend will be paid within a period of 30 days from the date of such approval.	11-Jul-2013
27-Apr-2012	D	Biocon Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 27, 2012 inter alia, have recommended a final dividend of 100% (Rs. 5.00 per share) on the share capital of the Company, subject to the approval of the members at the ensuing Annual General Meeting.	05-Jul-2012
28-Apr-2011	D	Biocon Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 28, 2011, inter alia, have declared an interim dividend of 30% (Rs 1.50 per share). A final dividend of 60% (Rs. 3.00 per share), has also been recommended by the Board subject to the approval of the members thereby taking the total dividend for the year to 90% (Rs 4.50 per share) on the share capital of the Company.	07-Jul-2011
28-Apr-2011	D	Biocon Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 28, 2011, inter alia, have declared an interim dividend of 30% (Rs 1.50 per share). A final dividend of 60% (Rs. 3.00 per share), has also been recommended by the Board subject to the approval of the members thereby taking the total dividend for the year to 90% (Rs 4.50 per share) on the share capital of the Company.	05-May-2011
29-Apr-2010	D	Biocon Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 29, 2010, inter alia, have recommended subject to the approval of the members dividend of 70% (Rs. 3.50) per share on the enhanced share capital of the Company.	08-Jul-2010
28-Apr-2009	D	Biocon Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 28, 2009, inter alia, has recommended, subject to the approval of the members dividend of 60% (Rs 3) per share on the enhanced share capital of the Company.	13-Jul-2009
22-Apr-2008	D	Biocon Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 22, 2008, inter alia, has also recommended a dividend for the year (subject to the approval of the members at the ensuing Annual General Meeting) of Rs 3/- per equity share (60%).	03-Jul-2008
22-Apr-2008	D	Biocon Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 22, 2008, inter alia, has also recommended a a special dividend of Rs 2/- per share (40%).	03-Jul-2008
19-Apr-2007	D	Biocon Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 19, 2007, inter alia, has recommended a dividend for the year (subject to the approval of shareholders at the ensuing Annual General Meeting of the Company) of Rs 3 per Equity shares of Rs 5 each (60%).	28-Jun-2007
27-Jun-2005	D	40% Dividend	29-Jun-2005
31-May-2019	B	1:1 Bonus Issue of Equity Shares Trading Members of the Exchange are hereby informed that, Biocon Ltd. has fixed the record date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Biocon Ltd. (532523) RECORD DATE 13/06/2019 PURPOSE Issue of 1 (One) Bonus equity share of Rs. 5/- each for every 1 (One) existing equity share of Rs. 5/- each held. Ex-Bonus basis from Date & Sett. No. 12/06/2019 DR-050/2019-2020 Trading Members of the Exchange are requested to take of it. (As Per BSE Notice Dated on 07.06.2019)	13-Jun-2019	1:1
08-Jun-2017	B	Trading Members of the Exchange are hereby informed that, Biocon Ltd. has fixed the record date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Biocon Ltd. (532523; 632523) RECORD DATE 17/06/2017 PURPOSE Issue of 2 (TWO) Bonus equity shares for every 1 (ONE) existing equity share held. Ex-Bonus basis from Date & Sett. No. 15/06/2017 DR-053/2017-2018 Trading Members of the Exchange are requested to take note of it.	17-Jun-2017	2:1
21-Aug-2008	B	SUB. :- Bonus issue of Biocon Ltd. (Scrip Code 532523) Trading Members of the Exchange are hereby informed that, Biocon Ltd. has fixed the Record Date for the purpose of Bonus Issue. The transactions in the equity shares of the company should be on an ex-bonus basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME CODE Biocon Ltd. 532523 RECORD DATE 12/09/2008 PURPOSE ONE fully paid up Bonus equity share for every ONE existing equity share held. Cum-Bonus basis up to Date & Sett. No. 10/09/2008 DR-113/2008- 2009 Ex-Bonus basis from Date & Sett. No. 11/09/2008 DR-114/2008-2009 Trading Members of the Exchange are requested to take note of it.	12-Sep-2008	1:1
10-Apr-2024	BC	BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2024 ,inter alia, to consider and approve Audited standalone and consolidated results and t	16-May-2024
21-Mar-2024	BC	Postal Ballot Notice Voting Results Scrutinizer''s Report (As per BSE Announcement Dated on 23/04/2024)	22-Apr-2024
10-Jan-2024	BC	BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 inter alia to consider and approve Please find attached the Board Meeting Intimation f	08-Feb-2024
27-Oct-2023	BC	Notice of Postal Ballot POM 30/11/2023 (As Per BSE Bulletin Dated on 27.10.2023) Newspaper advertisement regarding the Notice of Postal Ballot and Remote e-voting (As Per BSE Announcement	28-Nov-2023
09-Oct-2023	BC	BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve un-audited standalone and consolidated financial re	10-Nov-2023

Announcement Date23-May-2023

Ex Dividend Date07-Jul-2023

Dividend(%)30

Announcement Date28-Apr-2022

Ex Dividend Date30-Jun-2022

Dividend(%)10

Announcement Date25-Apr-2019

Ex Dividend Date18-Jul-2019

Dividend(%)10

Announcement Date26-Apr-2018

Ex Dividend Date19-Jul-2018

Dividend(%)20

Announcement Date27-Apr-2017

Ex Dividend Date20-Jul-2017

Dividend(%)20

Announcement Date11-Mar-2016

Ex Dividend Date17-Mar-2016

Dividend(%)100

Announcement Date27-Mar-2015

Ex Dividend Date09-Apr-2015

Dividend(%)100

Announcement Date25-Apr-2014

Ex Dividend Date10-Jul-2014

Dividend(%)100

Announcement Date26-Apr-2013

Ex Dividend Date11-Jul-2013

Dividend(%)100

Announcement Date26-Apr-2013

Ex Dividend Date11-Jul-2013

Dividend(%)50

Announcement Date27-Apr-2012

Ex Dividend Date05-Jul-2012

Dividend(%)100

Announcement Date28-Apr-2011

Ex Dividend Date07-Jul-2011

Dividend(%)60

Announcement Date28-Apr-2011

Ex Dividend Date05-May-2011

Dividend(%)30

Announcement Date29-Apr-2010

Ex Dividend Date08-Jul-2010

Dividend(%)70

Announcement Date28-Apr-2009

Ex Dividend Date13-Jul-2009

Dividend(%)60

Announcement Date22-Apr-2008

Ex Dividend Date03-Jul-2008

Dividend(%)60

Announcement Date22-Apr-2008

Ex Dividend Date03-Jul-2008

Dividend(%)40

Announcement Date19-Apr-2007

Ex Dividend Date28-Jun-2007

Dividend(%)60

Announcement Date27-Jun-2005

Ex Dividend Date29-Jun-2005

Dividend(%)40

No Rights has been declared by BIOCON

Book Closure

Record Date	Split Date	Purpose
16-May-2024	-	BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2024 ,inter alia, to consider and approve Audited standalone and consolidated results and t
22-Apr-2024	01 Jan'1900	Postal Ballot Notice Voting Results Scrutinizer''s Report (As per BSE Announcement Dated on 23/04/2024)
08-Feb-2024	-	BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 inter alia to consider and approve Please find attached the Board Meeting Intimation f
28-Nov-2023	01 Jan'1900	Notice of Postal Ballot POM 30/11/2023 (As Per BSE Bulletin Dated on 27.10.2023) Newspaper advertisement regarding the Notice of Postal Ballot and Remote e-voting (As Per BSE Announcement
10-Nov-2023	-	BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve un-audited standalone and consolidated financial re

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Biocon Ltd ₹311.05(+12.45/4.17%)	311.05	+12.45	37,344.66	25.02	0.00	3.44
Astrazeneca Pharma India Ltd ₹5,333.85(-7.40/-0.14%)	5,333.85	-7.40	13,334.63	68.03	83.60	20.36
Bliss GVS Pharma Ltd ₹129.20(+5.50/4.45%)	129.20	+5.50	1,352.61	60.30	19.82	1.38
Cipla Ltd ₹1,419.55(+18.35/1.31%)	1,419.55	+18.35	114,613.75	52.94	34.85	4.43
Abbott India Ltd ₹26,604.35(+188.60/0.71%)	26,604.35	+188.60	56,534.24	18.05	49.35	18.18
Amrutanjan Health Care Ltd ₹786.60(+88.65/12.70%)	786.60	+88.65	2,274.11	15.18	51.68	8.68

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	562.80	518.70	513.20	506.70	555.00	489.50
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	562.80	518.70	513.20	506.70	555.00	489.50
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	48.50	69.60	55.70	1917.60	59.90	1108.10
Total Income	611.30	588.30	568.90	2424.30	614.90	1597.60
Total Expenditure	491.50	456.70	441.20	550.70	517.90	461.70
PBIDT	119.80	131.60	127.70	1873.60	97.00	1135.90
Interest	56.00	55.00	48.30	48.10	21.40	0.00
PBDT	63.80	76.60	79.40	1825.50	75.60	1135.90
Depreciation	30.90	30.60	29.80	29.40	29.10	29.80
Tax	12.30	8.20	3.90	-12.90	11.30	118.60
Deferred Tax	-3.40	3.10	-0.90	-1.80	0.00	0.00
Reported Profit After Tax	24.00	34.70	46.60	1810.80	35.20	987.50
Extra-ordinary Items	0.00	-3.92	18.15	1853.60	0.00	900.99
Adjusted Profit After Extra-ordinary item	24.00	38.62	28.45	-42.80	35.20	86.51

EPS (Unit Curr.)	0.20	0.29	0.39	15.17	0.29	8.28
EPS (Adj) (Unit Curr.)	0.20	0.29	0.39	15.17	0.29	8.28
Calculated EPS (Unit Curr.)	0.20	0.29	0.39	15.08	0.29	8.23
Calculated EPS (Adj) (Unit Curr.)	0.20	0.29	0.39	15.08	0.29	8.23
Calculated EPS (Ann.) (Unit Curr.)	0.80	1.16	1.55	60.33	1.17	32.90
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.80	1.16	1.55	60.33	1.17	32.90
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	600.30	600.30	600.30	600.30	600.30	600.30
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	5.00	5.00	5.00	5.00	5.00	5.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	21.29	25.37	24.88	369.77	17.48	232.05
PBDTM(%)	11.34	14.77	15.47	360.27	13.62	232.05
PATM(%)	4.26	6.69	9.08	357.37	6.34	201.74

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	3953.70	3462.30	3422.60	3773.90	2941.10	2319.70
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	3953.70	3462.30	3422.60	3773.90	2941.10	2319.70
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	586.70	157.90	93.50	154.90	78.60	64.50
Total Income	4540.40	3620.20	3516.10	3928.80	3019.70	2384.20
Total Expenditure	3051.00	2768.90	2741.40	2819.70	2623.80	1894.30
PBIDT	1489.40	851.30	774.70	1109.10	395.90	489.90
Interest	266.70	247.70	233.00	248.80	120.30	30.00
PBDT	1222.70	603.60	541.70	860.30	275.60	459.90
Depreciation	414.50	389.30	358.00	363.70	301.10	230.80
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	82.70	52.30	43.40	72.40	59.00	147.30
Deferred Tax	-27.80	-10.70	-8.60	9.70	-63.80	0.00
Reported Profit After Tax	753.30	172.70	148.90	414.50	-20.70	81.80
Minority Interest After NP	93.30	47.10	47.50	101.30	21.10	34.90
Net Profit after Minority Interest	660.00	125.60	101.40	313.20	-41.80	46.90

Extra-ordinary Items	19.03	-18.14	0.00	-2.50	-212.40	-6.07
Adjusted Profit After Extra-ordinary item	640.97	143.74	101.40	315.70	170.60	52.97

EPS (Unit Curr.)	5.52	1.05	0.85	2.62	-0.35	0.39
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	600.30	600.30	600.30	600.30	600.30	600.30

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	37.67	24.59	22.63	29.39	13.46	21.12
PBDTM(%)	30.93	17.43	15.83	22.80	9.37	19.83
PATM(%)	19.05	4.99	4.35	10.98	-0.70	3.53

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	600.30	600.30	600.00	600.00	300.00	300.00
Reserves Total	10315.70	7492.60	7307.10	6937.30	6815.40	6438.60
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	10916.00	8092.90	7907.10	7537.30	7115.40	6738.60
Secured Loans	1297.70	75.90	0.00	0.00	69.30	130.20
Unsecured Loans	3.50	1.00	3.10	4.00	2.10	2.80
Total Debt	1301.20	76.90	3.10	4.00	71.40	133.00
Total Liabilities	12217.20	8169.80	7910.20	7541.30	7186.80	6871.60
APPLICATION OF FUNDS :
Gross Block	2472.00	2269.70	2098.10	1993.30	2581.30	2236.70
Less : Accumulated Depreciation	1510.60	1399.50	1300.00	1200.10	1480.20	1334.10
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	961.40	870.20	798.10	793.20	1101.10	902.60
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	343.50	284.90	179.20	151.90	254.50	318.50
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	9270.70	5280.00	5412.70	4952.80	4093.10	4199.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	560.10	541.50	430.90	534.70	801.90	561.70
Sundry Debtors	658.00	700.60	605.40	573.20	901.80	739.90
Cash and Bank	720.30	689.30	601.20	375.30	356.00	196.90
Loans and Advances	306.70	208.60	192.50	461.70	338.30	105.40
Total Current Assets	2245.10	2140.00	1830.00	1944.90	2398.00	1603.90
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	571.30	474.30	435.60	618.10	788.20	660.20
Provisions	125.40	115.70	112.70	109.20	135.10	105.60
Total Current Liabilities	696.70	590.00	548.30	727.30	923.30	765.80
Net Current Assets	1548.40	1550.00	1281.70	1217.60	1474.70	838.10
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	44.90	159.60	195.40	226.30	258.00	158.80
Deferred Tax Liability	22.10	39.60	49.00	46.80	56.10	56.60
Net Deferred Tax	22.80	120.00	146.40	179.50	201.90	102.20
Total Assets	12146.80	8105.10	7818.10	7295.00	7125.30	6360.40
Contingent Liabilities	681.70	525.70	1574.90	2225.80	2160.60	1677.70

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	600.30	600.30	600.00	600.00	300.00	300.00
Reserves Total	17266.60	7832.20	7026.90	6105.80	5798.00	4880.80
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	17866.90	8432.50	7626.90	6705.80	6098.00	5180.80
Minority Interest	4621.90	1037.50	880.70	677.30	608.90	467.70
Secured Loans	13795.00	2621.70	2295.20	2041.80	2214.20	2166.40
Unsecured Loans	4223.80	2524.90	2185.90	673.50	207.90	97.60
Total Debt	18018.80	5146.60	4481.10	2715.30	2422.10	2264.00
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	5161.90	2823.70	2696.60	1717.60	906.30	410.10
Total Liabilities	45669.50	17440.30	15685.30	11816.00	10035.30	8322.60
APPLICATION OF FUNDS :
Gross Block	35321.40	11233.00	10220.90	9147.40	7095.00	5873.80
Less: Accumulated Depreciation	5853.70	4664.00	3857.00	3176.30	2624.00	2174.30
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	29467.70	6569.00	6363.90	5971.10	4471.00	3699.50
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	7317.00	4110.40	2800.20	2196.00	1898.90	1302.80
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	2068.80	1587.90	1951.90	966.10	1011.80	675.20
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	4243.70	2298.20	1866.60	1435.90	1031.60	722.50
Sundry Debtors	3573.20	2058.20	1503.30	1223.70	1291.80	1063.90
Cash and Bank	2400.10	1747.50	2015.40	998.60	1057.20	1322.80
Loans and Advances	790.50	1060.70	1006.40	809.20	678.60	428.00
Total Current Assets	11007.50	7164.60	6391.70	4467.40	4059.20	3537.20
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	5617.90	2609.10	2542.90	2367.10	1952.80	1531.50
Provisions	373.60	292.30	261.80	230.90	204.30	135.60
Total Current Liabilities	5991.50	2901.40	2804.70	2598.00	2157.10	1667.10
Net Current Assets	5016.00	4263.20	3587.00	1869.40	1902.10	1870.10
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	1802.80	1150.10	307.70	368.00	558.10	295.90
Deferred Tax Liability	1883.60	909.10	32.30	29.80	233.40	102.50
Net Deferred Tax	-80.80	241.00	275.40	338.20	324.70	193.40
Other Assets	1880.80	668.80	706.90	475.20	426.80	581.60
Total Assets
Contingent Liabilities	947.80	844.40	700.00	1419.00	1601.10	588.90

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	111.00	253.50	375.00	305.70	89.10
Net Cash from Operating Activities	219.30	47.60	571.30	387.10	109.50
Net Cash Used In Investing Activities	-1173.10	-302.10	-720.60	-188.90	315.30
Net Cash Used In Financing Activities	1039.40	112.00	27.80	-128.90	-208.20
Net Inc./Dec In Cash And Cash Equivalents	85.60	-142.50	-121.50	69.30	216.60
Cash And Cash Equivalents At End Of The Year	196.60	111.00	253.50	375.00	305.70

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

60.64%

FII Shareholding

5.63%

DII Shareholding

13.68%

Public Shareholding

19.73%

**Promoter pledged shareholding 60.64%

About Biocon Ltd

Biocon Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 37344.66 crores. It has reported a sales of Rs. 562.8 crores and a net profit of Rs. 24 crores for the quarter ended December 2018. The company management includes Kiran Mazumdar Shaw, Kiran Mazumdar Shaw,Ravi Mazumdar,Vijay Kumar Kuchroo,M Damodaran,Bobby Parikh,Mayank Verma,SIDDHARTH MITTAL,Eric Vivek Mazumdar,Naina Lal Kidwai,Peter John Bains (Biocon Ltd) among others.

Chairman

Kiran Mazumdar Shaw

Registered office

20th KM Hosur Road Hebbagodi,Electronic City P O,Bangalore,Karnataka,560100

FAX :91-80-28523423

Background

Incorporation Year1978

Face Value₹5

Market Lot1

How to buy Biocon shares on nse?

To buy Biocon shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Biocon share price today?

The Biocon shares price on nse is Rs.311.05 today.

What is the market cap of Biocon shares on BSE ?

The company has a market capitalization of Rs.37344.66Cr

What is the PE & PB ratio of Biocon shares ?

PE is 0 and PB is 3.44

What is the 52 Week High and Low of Biocon shares?

Biocon stock price high: Rs.314.6 Biocon stock price low: Rs.217.5

What will be the future of Biocon shares?

A company operating in the pharmaceutical sector, Biocon’s shares have been witnessing steady growth between 5th and 10th May 2023. The Serum Institute of Life Sciences will invest 300 million dollar in Biocon Biologicals, cementing the company’s prospects. Thus, the future of Biocon looks promising.

What are the factors that influence the share price of Biocon?

The factors affecting the stock price of Biocon are as follows –

Demand and supply mechanism
Market sentiments
The financial performance of the company and reported profits
The future growth potential
The overall performance of the pharma sector
Economic and political factors
International factors, etc.

What is the long-term growth potential of Biocon?

Over the long-term horizon, Biocon is expected to grow its business. Since the company has domestic and international demand and the pharma sector is booming, you might benefit from investing in Biocon over the long run. Moreover, with a long-term horizon, you can avoid short-term volatility risks of the market and get capital appreciation on your investment.

What is the upcoming dividend for Biocon shares?

As per the financial results of the financial year 2022-23, the company has declared a final dividend of 10% of the face value of each share. This converts to a dividend of 0.50.

How often are dividends paid on Biocon shares?

The frequency of dividend payments depends on the profitability of the company. Over the past few years, here’s when the company has paid a dividend –

Dividend date	Dividend amount
28th April 2022	Final dividend of 0.50
25th April 2019	Final dividend of 0.50
26th April 2018	Final dividend of 1.00
27th April 2017	Final dividend of 1.00